Work

Abstract 15515: SGLT2 Inhibitor Empagliflozin Increases Fatty Acid Oxidation, Coupling Between Glycolysis and Glucose Oxidation, and Decreases Left Ventricular Hypertrophy in Mice With Hypertrophic Cardiomyopathy Due to Myosin R403Q Mutation

Year: 2023

Type: conference-abstract

Source: Circulation

DOI: 10.1161/circ.148.suppl_1.15515

Authors: Tomas Baka, Jarrod Moore, Fuzhong Qin, Huamei He, Jordan M Chambers, Dominique Croteau, Raghuveera Goel, Aifeng Zhang, Hunter Smith, James A Balschi, David R Pimentel, Christine E Seidman, Jonathan G Seidman, Andrew Emili, Wilson S Colucci, Ivan Luptak

Institutions: Boston University, Brigham and Women's Hospital, Harvard University

Language: English

Topic: Cardiomyopathy and Myosin Studies

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4389944302

Cites:

Cited by: 3

Related to: 10